The impact of age on survival in CLL patients receiving ibrutinib as initial therapy Meeting Abstract


Authors: Ujjani, C.; Mato, A.; Hill, B.; Allan, J.; Lansigan, E.; Skarbnik, A.; Jacobs, R.; Thompson, M.; Svoboda, J.; Tuncer, H. H.; Pagel, J.; Brander, D.; Cheson, B. D.; Barr, P.; Zent, C. S.; Rhodes, J.; Roeker, L.; Pu, J.; Handunnetti, S.; Nabhan, C.; Shah, N.; Goy, A.; Pickens, P.; Schuster, S.; Lamanna, N.; Sehgal, A.; Tam, C.; Shadman, M.
Abstract Title: The impact of age on survival in CLL patients receiving ibrutinib as initial therapy
Meeting Title: 18th International Workshop on Chronic Lymphocytic Leukemia
Journal Title: Leukemia and Lymphoma
Volume: 61
Issue: Suppl. 1
Meeting Dates: 2019 Sept 20-23
Meeting Location: Edinburgh, United Kingdom
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2020-01-01
Start Page: 156
End Page: 158
Language: English
ACCESSION: WOS:000534385400113
PROVIDER: wos
PUBMED: 32436402
DOI: 10.1080/10428194.2020.1732667
Notes: Meeting Abstract: 2073 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato
  2. Lindsey Elizabeth Roeker
    132 Roeker